Stanford University
Showing 641-650 of 13,057 Results
-
Simar Bajaj
MD Student, expected graduation Spring 2031
BioSimar Bajaj is a medical student and Knight-Hennessy Scholar at Stanford University School of Medicine with interests in internal medicine, health policy, and science journalism. He studied Global Health Science and Epidemiology at the University of Oxford as a Marshall Scholar and studied Chemistry and the History of Science at Harvard University, where he graduated summa cum laude.
His research focuses on stigmatized diseases like obesity, lung cancer, and substance use disorder with first-author work in The Lancet, New England Journal of Medicine, Nature Medicine, British Medical Journal, Annals of Internal Medicine, and Annals of Surgery.
Simar is also an an award-winning journalist and, until recently, worked as a health and wellness reporter at the New York Times (https://www.nytimes.com/by/simar-bajaj). His writing has also appeared in NPR, The Atlantic, The Economist, The Washington Post, National Geographic, and more. He is currently working on a book about stigmatized diseases. -
Vikram S Bajaj
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioAdj. Professor, Stanford Radiology.
Managing Director, Foresite Capital Management
Co-Founder/CEO, Foresite Labs
Previous:
Chief Scientific Officer, GRAIL
Chief Scientific Officer and Co-Founder, Verily (Google Life Sciences) -
Sepideh Bajestan, MD, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsNeuropsychiatry
Functional Neurological Symptom Disorders, Psychogenic Non-Epileptic Seizures
Group and Individual Psychotherapy
Impulse Control Disorders -
Julie Baker
Professor of Genetics
Current Research and Scholarly InterestsWe examine how cells communicate and function during fetal development. The work in my laboratory focuses on the establishment of specific cell fates using genomics to decipher interactions between chromatin and developmental signaling cascades, between genomes and rapidly evolving cell types, and between genomic copy number variation and gene expression. In recent years we have focused on the vastly understudied biology of the trophoblast lineage, particularly how this lineage evolved.
-
Justin Nathaniel Baker
Deborah E. Addicott - John A. Kriewall and Elizabeth A. Haehl Family Professor of Pediatrics
BioAs a Pediatric Oncologist, Palliative Care Physician, and Phase I and End– of– Life Care Clinical Investigator, I am intimately aware of the distress experienced by children with advanced cancer and the ethical and end– of– life/bereavement issues surrounding their disease progression. I currently serve as the Chief of the Division of Quality of Life and Pediatric Palliative Care here at Stanford, as well as the Director of the Quality of Life for All (QoLA) Program. Additionally, I serve as the Associate Chief Quality Officer for Patient Experience and Holistic Care. In my past career at St Jude, I served as the Director of our large Pediatric Hematology/Oncology Fellowship Program for more than a decade. My research interests include ethical considerations surrounding enrollment in Phase I clinical trials, AYA palliative oncology care, end– of– life decision making, grief and bereavement, integrating palliative care into the ongoing care of children with cancer as well as patient– reported outcomes and pain and symptom control in the context of pediatric oncology care. I have received significant extramural funding for my research, and I have participated in dozens of studies related to pediatric palliative care. I have authored ~300 academic works on a broad array of palliative care subjects. In sum, I am a recognized global expert and leader in the field of Pediatric Palliative Care.
